Series A Round

Therini Bio is a biotechnology company focused on developing innovative therapeutics for neurodegenerative diseases. The company leverages advanced technologies to create solutions that address unmet medical needs in the field of neurology. Their research includes the use of biomarker discovery and drug development aimed at conditions such as Alzheimer's disease, Parkinson's disease, and other related disorders.